Clinical trial · Interventional
Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy
NCT04566302CI-TRIAL-00096859completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pigmented Lesions | — | UNRESOLVED | — |
| Pigmented Moles | Pigmented Nevus | ALIAS | 0.90 |
| Pigmented Skin Lesion | — | UNRESOLVED | — |
| Skin Lesion | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SECM Skin Imaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- SECM Skin Imaging
- description
- The SECM skin imaging procedure will be very similar to that by the FDA approved RCM devices. First, the skin lesion (such as a mole) will be identified on a forearm of the subject. The lesion will be imaged first with a dermatoscope, and then with the SECM device. A dermatoscope is a hand-held device used for the visual observation of the epidermis. It is a superior surface contact microscope used to examine skin lesions.
- interventionNames
- Device: SECM Skin Imaging
Primary outcomes (1)
- measure
- Number of Participants With Quality Skin Images Obtained From SECM Device
- timeFrame
- Approximate 30 minute study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Healthy adults * 18 years of age or older * Capable of giving informed consent * Pigmented lesions (such as moles) present on the forearm Exclusion Criteria: * Unable to provide consent * Open cuts/sores on the skin, skin infection, or any contagious skin condition * Pregnant women (according to subject) * Employees under the direct supervision of the investigator
References
Publications (0)
Data not yet available
No reference posted for this study.